Enko Chem, Inc. announced that it will issue 16,459,544 series C preferred shares at issue price of $4.8604 per share for the gross proceeds $79,999,967.658 in funding on July 15, 2022. The shares will be convertible in common shares at a price of $4.8604 per share. The company will receive $69,493,377 pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.57 AUD | -3.38% | -8.96% | -12.45% |
05-24 | Citi Downgrades Nufarm to Neutral From Buy; Price Target is AU$4.80 | MT |
05-24 | Citi Downgrades Nufarm to Neutral From Buy, Price Target is AU$4.80 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.45% | 1.16B | |
-1.54% | 3.49B | |
-24.51% | 2.03B | |
-10.52% | 1.91B | |
-2.34% | 1.78B | |
-1.86% | 1.67B | |
-0.48% | 1.13B | |
-23.14% | 1.02B | |
-6.09% | 972M | |
-17.43% | 812M |
- Stock Market
- Equities
- NUF Stock
- News Nufarm Limited
- Enko Chem, Inc. announced that it expects to receive $79.999968 million in funding